Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Feb 12;23(5):733–742. doi: 10.1158/1535-7163.MCT-23-0459

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©2024 The Authors; Published by the American Association for Cancer Research

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

PMC Copyright notice

Figure 2. The progression-free survival (PFS) and overall survival (OS) in Cohorts 1 and 2. In Cohort 1, long-term survival patients have mPFS 27.05 months and mOS NR months, and short-term survival patients have mPFS 2.79 months and mOS 10.59 months (A and B). Among the patients in Cohort 2, long-term survival patients have mPFS 27.35 months and mOS NR months, and short-term survival patients have mPFS 3.77 months and mOS 12.17months (C and D). — The progression-free survival (PFS) and overall survival (OS) in Cohorts 1 and 2. In Cohort 1, long-term survival patients have mPFS 27.05 months and mOS NR months, and short-term survival patients have mPFS 2.79 months and mOS 10.59 months (A and B). Among the patients in Cohort 2, long-term survival patients have mPFS 27.35 months and mOS NR months, and short-term survival patients have mPFS 3.77 months and mOS 12.17months (C and D).